化便微生物群在囊中的转移用于复发性Clostridioides difficile感染
Lourdes Daneri1, Alicia Urbano2, Rosa Escudero-Sánchez3
1Internal Medicine Department, Hospital Principe de Asturias, Alcalá de Henares, Madrid Spain.
International journal of antimicrobial agents
|July 3, 2025
概括
软化,封装的便微生物群移植 (FMT) 对复发性Clostridioides difficile感染 (CDI) 有效,治疗率高,在这项欧洲研究中没有发现严重的不良反应.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 便微生物群移植 (FMT) 建议用于复发性困难菌感染 (CDI).
- 软化和封装的FMT提供了改善的患者方便.
- 欧洲关于封装FMT疗效的数据有限.
研究的目的:
- 在欧洲队列中评估冷化,封装的FMT对复发性CDI的有效性和安全性.
- 介绍这种新型治疗方法的临床经验.
主要方法:
- 36名患有复发性CDI的患者进行了回顾性队列研究,这些患者接受了封装FMT的治疗.
- 随访时间至少为12周.
- 主要结局:三个月后CDI复发.
主要成果:
- 75%的患者 (27/36) 在三个月后没有CDI.
- 包括救援治疗在内的整体治愈率达到91.7%.
- 没有报告严重的不良影响.
结论:
- 化,封装的FMT在复发性CDI中表现出可接受的有效性.
- FMT失败往往可以通过后续干预成功治疗,不一定重复FMT.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
308
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
308
Drugs for Treatment of Constipation-Predominant IBS
350
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
350
Drugs for Treatment of Ulcerative Colitis in IBD
242
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
242
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
321
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
321
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
205
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
205


